Therapeutics Supplements and Botanicals

Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake

Nagano M, Shimizu K, Kondo R, Hayashi C, Sato D, Kitagawa K, Ohnuki K

Published August 2010 Biomedical Research
DOI 10.2220/biomedres.31.231 PMID 20834180

RRM Academy Synopsis

Depression scores fell within a lion's mane group in a four-week trial

In a placebo-controlled trial of 30 women, depression scores fell significantly over four weeks in the lion's mane group. The drop in depression score didn't differ significantly from the placebo group. On two complaint items, "palpitation" and "incentive," the lion's mane group scored lower than placebo.

Key Findings

  • Of 30 women randomized, 26 were analyzed (12 lion's mane, 14 placebo). Two ate under 75% of their cookies, one bled 18 days a month and one sent no report.
  • In the lion's mane group, the depression score (CES-D) fell significantly from before to after four weeks (P = 0.033). The change in depression score didn't differ significantly between groups.
  • The total indefinite complaints score (ICI) also fell within the lion's mane group (P = 0.004).
  • Against placebo, lion's mane scores were significantly lower on two ICI items, "palpitation" (P = 0.032) and "incentive" (P = 0.047).
  • Three more items, "irritating" (P = 0.076), "anxious" (P = 0.067) and "concentration" (P = 0.090), trended lower than placebo without reaching significance. Sleep quality scores didn't differ between groups.

Interpretation

Researchers randomly assigned women to cookies with or without powdered lion's mane, the mushroom Hericium erinaceus. The trial was placebo-controlled and double-blind, so neither the women nor the researchers knew who got which. The 30 women had "indefinite complaints," the authors' term for everyday symptoms without a diagnosed disease. All outcomes were questionnaire scores, and the depression score fell within the lion's mane group from before to after. Against placebo, two single complaint items differed significantly. The authors call for further studies to identify the active compounds and how they work.

RRM Context

RRM regards a woman's mood as part of her whole-body and hormonal health, and it looks for underlying causes. To understand how lion's mane might work, the authors propose future research on physical markers such as hormones and nerve activity. That kind of link would connect a food study like this one to the cause-based questions RRM asks.

Abstract

Hericium erinaceus, a well known edible mushroom, has numerous biological activities. Especially hericenones and erinacines isolated from its fruiting body stimulate nerve growth factor (NGF) synthesis, which expects H. erinaceus to have some effects on brain functions and autonomic nervous system. Herein, we investigated the clinical effects of H. erinaceus on menopause, depression, sleep quality and indefinite complaints, using the Kupperman Menopausal Index (KMI), the Center for Epidemiologic Studies Depression Scale (CES-D), the Pittsburgh Sleep Quality Index (PSQI), and the Indefinite Complaints Index (ICI). Thirty females were randomly assigned to either the H. erinaceus (HE) group or the placebo group and took HE cookies or placebo cookies for 4 weeks. Each of the CES-D and the ICI score after the HE intake was significantly lower than that before. In two terms of the ICI, "insentive" and "palpitatio", each of the mean score of the HE group was significantly lower than the placebo group. "Concentration", "irritating" and "anxious" tended to be lower than the placebo group. Our results show that HE intake has the possibility to reduce depression and anxiety and these results suggest a different mechanism from NGF-enhancing action of H. erinaceus.

Topics

Related research

Therapeutics › Supplements and Botanicals › Herbal and Botanical Products
Mayumi Nagano, Kuniyoshi Shimizu, Ryuichiro Kondo, Chickako Hayashi, Daigo Sato, Katsuyuki Kitagawa, Koichiro Ohnuki
M Nagano, K Shimizu, R Kondo, C Hayashi, D Sato, K Kitagawa, K Ohnuki
PMID 20834180 20834180 DOI 10.2220/biomedres.31.231 10.2220/biomedres.31.231 Nagano et al. 2010, Nagano 2010